Castle Hook Partners LP bought a new position in IQVIA Holdings Inc. (NYSE:IQV – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 165,646 shares of the medical research company’s stock, valued at approximately $39,253,000. IQVIA comprises about 0.7% of Castle Hook Partners LP’s investment portfolio, making the stock its 26th biggest holding.
Other large investors have also made changes to their positions in the company. First Foundation Advisors grew its holdings in IQVIA by 3.8% during the 2nd quarter. First Foundation Advisors now owns 1,161 shares of the medical research company’s stock worth $245,000 after acquiring an additional 43 shares during the last quarter. Invera Wealth Advisors LLC grew its holdings in IQVIA by 0.3% during the 2nd quarter. Invera Wealth Advisors LLC now owns 14,506 shares of the medical research company’s stock worth $3,183,000 after acquiring an additional 46 shares during the last quarter. Private Trust Co. NA grew its holdings in IQVIA by 10.7% during the 3rd quarter. Private Trust Co. NA now owns 485 shares of the medical research company’s stock worth $115,000 after acquiring an additional 47 shares during the last quarter. Oregon Public Employees Retirement Fund grew its holdings in IQVIA by 0.3% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 15,668 shares of the medical research company’s stock worth $3,313,000 after acquiring an additional 48 shares during the last quarter. Finally, Continuum Advisory LLC grew its holdings in IQVIA by 3.3% during the 2nd quarter. Continuum Advisory LLC now owns 1,538 shares of the medical research company’s stock worth $325,000 after acquiring an additional 49 shares during the last quarter. Institutional investors own 89.62% of the company’s stock.
IQVIA Stock Performance
Shares of IQV stock opened at $201.44 on Thursday. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. The company has a market capitalization of $36.56 billion, a P/E ratio of 26.44, a price-to-earnings-growth ratio of 2.10 and a beta of 1.51. The company’s 50 day moving average price is $220.36 and its two-hundred day moving average price is $226.57. IQVIA Holdings Inc. has a 52 week low of $187.62 and a 52 week high of $261.73.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Analysis on IQVIA
About IQVIA
IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
Read More
- Five stocks we like better than IQVIA
- Insider Buying Explained: What Investors Need to Know
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to Buy Cheap Stocks Step by Step
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Conference Calls and Individual Investors
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQV – Free Report).
Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.